260 related articles for article (PubMed ID: 24148766)
1. α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
Ryan BJ; Lourenço-Venda LL; Crabtree MJ; Hale AB; Channon KM; Wade-Martins R
Free Radic Biol Med; 2014 Feb; 67():58-68. PubMed ID: 24148766
[TBL] [Abstract][Full Text] [Related]
2. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
3. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
eNeuro; 2017; 4(6):. PubMed ID: 29177188
[TBL] [Abstract][Full Text] [Related]
5. The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons.
Fountaine TM; Venda LL; Warrick N; Christian HC; Brundin P; Channon KM; Wade-Martins R
Eur J Neurosci; 2008 Dec; 28(12):2459-73. PubMed ID: 19032594
[TBL] [Abstract][Full Text] [Related]
6. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
Seo MH; Yeo S
Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
[TBL] [Abstract][Full Text] [Related]
7. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
Kawahata I; Bousset L; Melki R; Fukunaga K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
[TBL] [Abstract][Full Text] [Related]
8. RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport.
Fountaine TM; Wade-Martins R
J Neurosci Res; 2007 Feb; 85(2):351-63. PubMed ID: 17131421
[TBL] [Abstract][Full Text] [Related]
9. Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins.
Callizot N; Combes M; Henriques A; Poindron P
PLoS One; 2019; 14(4):e0215277. PubMed ID: 31022188
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
[TBL] [Abstract][Full Text] [Related]
11. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
[TBL] [Abstract][Full Text] [Related]
12. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.
Wang X; Su B; Liu W; He X; Gao Y; Castellani RJ; Perry G; Smith MA; Zhu X
Aging Cell; 2011 Oct; 10(5):807-23. PubMed ID: 21615675
[TBL] [Abstract][Full Text] [Related]
13. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
Sampath C; Kalpana R; Ansah T; Charlton C; Hale A; Channon KM; Srinivasan S; Gangula PR
Dig Dis Sci; 2019 Dec; 64(12):3502-3517. PubMed ID: 31187328
[TBL] [Abstract][Full Text] [Related]
14. Uncoupling of ATP-depletion and cell death in human dopaminergic neurons.
Pöltl D; Schildknecht S; Karreman C; Leist M
Neurotoxicology; 2012 Aug; 33(4):769-79. PubMed ID: 22206971
[TBL] [Abstract][Full Text] [Related]
15. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.
Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA
J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
17. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
[TBL] [Abstract][Full Text] [Related]
18. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein.
Vicario M; Cieri D; Vallese F; Catoni C; Barazzuol L; Berto P; Grinzato A; Barbieri L; Brini M; Calì T
Cell Death Dis; 2019 Nov; 10(11):857. PubMed ID: 31719530
[TBL] [Abstract][Full Text] [Related]
19. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
